LilyLink
LilyLink is a San Francisco-based digital health company providing an end-to-end gestational diabetes management platform that integrates CGM and glucometer data for OBGYN practices, maternal-fetal medicine clinics, and their pregnant patients.
- Company typePrivate
- Founded2024
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What LilyLink does
LilyLink Inc. is a San Francisco-based digital health company founded in 2024 by Tyler Rice (Co-Founder, CEO) and Madison Stanford (Co-Founder, CTO) that has built an end-to-end gestational diabetes (GDM) management platform for OBGYN practices, maternal-fetal medicine (MFM) clinics, and the pregnant patients they serve. The company launched out of stealth on November 13, 2024, targeting the segment between general pregnancy apps and general diabetes apps that, per the company's positioning, inadequately serves GDM patients. Its product comprises three integrated components: a patient-facing mobile app (iOS and Android) with AI-driven one-tap meal-photo entry, weekly glucose summaries, and Apple Health integration; an EHR-integrated provider portal that aggregates CGM and glucometer data, performs risk stratification, and surfaces ACOG-compliant postprandial logs; and a virtual care team of GDM-trained registered dietitians and CDCES-certified diabetes educators.
Technically, the platform integrates with the leading CGM hardware — Dexcom G7 and Abbott FreeStyle Libre 2/3 — and with Bluetooth glucometers from Ascensia (ContourNext) and Roche (OneTouch, Accu-Chek), and applies pregnancy-specific glucose thresholds (fasting under 95 mg/dL, postprandial under 140 mg/dL 1-hour or 120 mg/dL 2-hour per ACOG) rather than standard diabetes ranges. The stated technical differentiators are domain specialization (pregnancy-specific targets and postprandial log generation), EHR interoperability, and ease-of-use implementation (one-tap meal entry, automated postprandial logging). The company is HIPAA-compliant and describes itself as a closed, end-to-end solution with no public API or developer portal.
LilyLink operates as a B2B2C enterprise platform. OB practices and MFM clinics are sold to directly via a "Request a Demo" funnel backed by content marketing, downloadable reimbursement guides, paid digital advertising, and PR/earned media; once onboarded, practices prescribe/enroll their GDM patients, who access the patient app via provider-issued access codes. Revenue is generated per enrolled patient primarily through Remote Patient Monitoring (RPM) billing, leveraging CPT codes 99453, 99454, 99457, and 99458, billed outside the global obstetric package at $150-$300 per patient per month. The company separately structures revenue as a subscription/SaaS for platform access, with quote-based pricing that is not publicly disclosed. Named customers prominently include Maternal Fetal Medicine Associates (Dr. Jennifer Lam-Rachlin) and a logo strip of additional OB/MFM practices (MFM + Sinai, TWC, TPC, OSU, TLC). No external investors, funding rounds, or ownership beyond the co-founders are disclosed.
LilyLink firmographics
Firmographics- Name
- LilyLink
- Legal name
- LilyLink Inc.
- Website
- https://lilylink.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- LilyLink is a San Francisco-based digital health company providing an end-to-end gestational diabetes management platform that integrates CGM and glucometer data for OBGYN practices, maternal-fetal medicine clinics, and their pregnant patients.
- Ownership category
- akta.pro rank
LilyLink industry classification
Industry- Product category
- Digital Health - Maternal Diabetes Management Software
- NAICS
- All Other Outpatient Care Centers (621498)
- SIC
- Services-Health Services (8000), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)
- akta.pro secondary industries
- Gestational Diabetes (HLAKADAD), Diabetes Education & Insulin Management (Home-Based) (HSABACAJ), Continuous Glucose Monitoring (CGM) Systems (HLAHAHAA)
Keywords
Where LilyLink is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
LilyLink business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Remote Patient Monitoring (RPM) Billing: Providers bill for RPM activities including device setup, training, glucose data review, and patient interactions using CPT codes 99453, 99454, 99457, and 99458. Reimbursement ranges from $150 to $300 per patient per month, billed outside the global obstetric package. This represents both a value driver for practices and the company's primary revenue mechanism.
- Platform/SaaS Subscription: The company operates as a platform provider to OB practices, who pay for access to the LilyLink platform including the provider portal, patient app, and virtual care team support. Revenue is generated per patient enrolled on the platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Enterprise B2B pricing for OB practices — not publicly disclosed |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
LilyLink product offering
Product offeringCore offering
LilyLink is a unified, end-to-end digital health platform purpose-built for gestational diabetes mellitus (GDM) management. It comprises a pregnancy-specific patient mobile app with AI-driven one-tap meal entry, an EHR-integrated provider portal for risk stratification and remote patient monitoring (RPM) billing, and a virtual care team of GDM-trained dietitians and CDCES providers. The platform integrates with continuous glucose monitors and Bluetooth glucometers to deliver ACOG-aligned care for obstetric practices and their patients.
Product overview
LilyLink is a unified gestational diabetes management platform purpose-built for maternal diabetes care. The platform consists of three integrated components: the LilyLink Patient Mobile App (pregnancy-specific app with AI-driven one-tap meal logging, CGM/glucometer sync, and Apple Health integration), the LilyLink Provider Portal (EHR-integrated dashboard for patient data summaries, risk stratification, and RPM billing), and the LilyLink Virtual Care Team (GDM-trained dietitians and CDCESs providing nutrition counseling as an extension of clinic staff). Together these address the gap that general pregnancy apps and diabetes apps leave unfilled in GDM care.
Differentiator
Problem solved
Functional benefit
Products and services
- LilyLink Platform A unified gestational diabetes management platform for OB practices and their patients, encompassing the pregnancy-specific patient mobile app, EHR-integrated provider portal, CGM and glucometer integration, remote patient monitoring (RPM) billing tools, and a virtual care team of GDM-trained dietitians and certified diabetes educators (CDCES). Purpose-built for ACOG-concordant maternal diabetes care.
- LilyLink Patient Mobile App A pregnancy-specific mobile app for patients diagnosed with gestational diabetes, featuring AI-driven one-tap meal photo entry, automated postprandial logging, weekly glucose summaries, Apple Health integration, and compatibility with leading CGMs and Bluetooth glucometers. Eliminates the need for paper glucose logs. Activated with a provider-issued access code.
- LilyLink Provider Portal An EHR-integrated provider dashboard that aggregates patient CGM and glucometer data into quick summaries, enables risk stratification, and tracks remote patient monitoring (RPM) activities for reimbursable CPT code billing (99453, 99454, 99457, 99458). Designed for ACOG guideline-concordant gestational diabetes care within OB practice workflows.
- LilyLink Virtual Care Team A virtual team of GDM-trained registered dietitians and Certified Diabetes Care and Education Specialists (CDCES) who provide diabetes training and nutrition counseling to enrolled patients as an extension of the clinic's staff, available via chat within the platform.
Quantifiable outcome
- 7+ hours saved per patient in manual data entry during a typical GDM pregnancy
- +2 more outcomes
Companies that use LilyLink
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
LilyLink technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability3 records
Feature6 records
LilyLink partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- DexcomcoreDexcom G7 CGM is explicitly listed as a compatible device on the LilyLink platform. LilyLink integrates with Dexcom CGM data, transforming raw glucose readings into pregnancy-specific postprandial logs conforming to ACOG guidelines.
- Abbott (FreeStyle Libre)coreFreeStyle Libre 2 and FreeStyle Libre 3 are listed as compatible devices. LilyLink integrates with Abbott's CGM systems, providing pregnancy-specific data visualization and logging for GDM patients using these devices.
- Ascensia (ContourNext)coreContourNext Bluetooth glucometer is listed as a compatible device, with data integrated into the LilyLink platform for glucose tracking and RPM billing.
- Roche (OneTouch, AccuChek)coreOneTouch and AccuChek Bluetooth glucometers are listed as compatible devices, with data flowing into the LilyLink provider portal and patient app.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
LilyLink competitors and assessment
Company assessmentDirect peers
- Babyscripts: Maternal health digital health platform selling B2B to OB practices with virtual care, RPM, and patient engagement tools — directly comparable B2B2C go-to-market in obstetrics, though broader in scope than gestational diabetes.
- MySugr (Roche): Consumer diabetes self-management app with Bluetooth glucometer integration and coaching, now part of Roche. Comparable as a digital companion app layered on top of CGM/glucometer hardware, though not pregnancy-specific.
- Glooko: Diabetes data management platform that aggregates CGM and glucometer data for patients and providers. Comparable technology stack (multi-CGM ingestion, provider dashboards, EHR integration) for chronic diabetes management.
- Tidepool: Diabetes data platform supporting multiple CGMs and pumps with provider-facing analytics. Comparable as device-agnostic diabetes data infrastructure with clinical workflow integration, including for type 1 populations.
- Mahmee: Maternal health platform providing in-person and virtual support to expectant and new mothers, often contracted through health systems. Comparable B2B2C model into the maternal health buyer, though less diabetes-specialized.
- One Drop: Direct-to-consumer and B2B digital diabetes management platform with coaching, CGM integration, and predictive analytics. Comparable technology layer for chronic diabetes self-management, though broader in target population.
Broad incumbents
- Dexcom: Leading CGM manufacturer with FDA-cleared pregnancy indications and consumer apps (Dexcom Clarity, Stelo). Comparable as the upstream device provider and a potential competitor if it embeds pregnancy-specific workflows natively.
- Abbott (FreeStyle Libre): Global CGM market leader with LibreView consumer platform and FDA-cleared pregnancy indications. Comparable as an integration partner and a strategic risk if Abbott launches pregnancy-specific digital features.
- Omada Health: Digital chronic condition management platform (diabetes, hypertension, prediabetes) sold to employers and payers with RPM and coaching. Comparable B2B reimbursement-driven digital health model, though focused on type 2 rather than GDM.
- Virta Health: Digital therapeutic for type 2 diabetes reversal using continuous remote monitoring and coaching. Comparable as a venture-backed, reimbursement-aligned digital diabetes platform targeting similar B2B buyers (payers, providers).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LilyLink social profiles
Digital presenceLilyLink compliance and trust
Trust signalCompliance1 record
LilyLink financial estimates
Financial estimateRevenue estimate
Valuation estimate
LilyLink leadership team
Management profileNumber of profiles
Profiles3 records
LilyLink funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LilyLink M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LilyLink
What does LilyLink do?
LilyLink is a unified, end-to-end digital health platform purpose-built for gestational diabetes mellitus (GDM) management. It comprises a pregnancy-specific patient mobile app with AI-driven one-tap meal entry, an EHR-integrated provider portal for risk stratification and remote patient monitoring (RPM) billing, and a virtual care team of GDM-trained dietitians and CDCES providers. The platform integrates with continuous glucose monitors and Bluetooth glucometers to deliver ACOG-aligned care for obstetric practices and their patients.
Is LilyLink a public or private company?
LilyLink is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was LilyLink founded?
LilyLink was founded in 2024. It employs 1 to 10 people.
Where is LilyLink based?
LilyLink is headquartered in San Francisco, United States, in the North America region.
How does LilyLink make money?
Two revenue lines are on record. Remote Patient Monitoring (RPM) Billing is the primary driver. The others are platform/SaaS Subscription.
Who are LilyLink's main competitors?
Direct peers on record are Babyscripts, MySugr (Roche), Glooko, Tidepool, Mahmee and One Drop. Broad incumbents are Dexcom, Abbott (FreeStyle Libre), Omada Health and Virta Health.
Does LilyLink have an API?
No public API is recorded for LilyLink.
What industry is LilyLink in?
LilyLink's product category is Digital Health - Maternal Diabetes Management Software. Its primary akta.pro industry code is HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators), with a secondary code of HLAKADAD, Gestational Diabetes. Its NAICS code is 621498 and its SIC code is 8000.